OS Therapies IncorporatedOSTXNYSE
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank8
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Latest
-99.39%
↓ 192% vs avg
Percentile
P8
Near historical low
Streak
1 qtr
Consecutive declineDecelerating
Average
-34.08%
Historical baseline
PeriodValue
Q3 2025-99.39%
Q2 202531.43%
Q1 2025-44.95%
Q4 202429.85%
Q3 2024-284.12%
Q2 2024-37.32%
Q1 202426.34%
Q4 20230.62%
Q3 2023-5.48%
Q2 2023-94.09%
Q1 20230.00%
Q4 20220.00%
Q1 20220.00%
Q4 20210.00%